Your browser doesn't support javascript.
loading
Programmed death-1 inhibition and atherosclerosis: can nivolumab vanish complicated atheromatous plaques?
Gelsomino, F; Fiorentino, M; Zompatori, M; Poerio, A; Melotti, B; Sperandi, F; Gargiulo, M; Borghi, C; Ardizzoni, A.
Afiliação
  • Gelsomino F; Medical Oncology, University Hospital of Parma, Parma, Italy.
  • Fiorentino M; Medical Oncology Unit, Policlinico S.Orsola-Malpighi, Bologna, Italy.
  • Zompatori M; Laboratory of Molecular Pathology, Addarii Institute of Oncology, Bologna, Italy.
  • Poerio A; Unit of Radiology, Policlinico S.Orsola-Malpighi, University of Bologna, Bologna, Italy.
  • Melotti B; Unit of Radiology, Policlinico S.Orsola-Malpighi, University of Bologna, Bologna, Italy.
  • Sperandi F; Medical Oncology Unit, Policlinico S.Orsola-Malpighi, Bologna, Italy.
  • Gargiulo M; Medical Oncology Unit, Policlinico S.Orsola-Malpighi, Bologna, Italy.
  • Borghi C; Unit of Vascular Surgery, Policlinico S.Orsola-Malpighi, University of Bologna, Bologna, Italy.
  • Ardizzoni A; Unit of Internal Medicine, Policlinico S.Orsola-Malpighi, University of Bologna, Bologna, Italy.
Ann Oncol ; 29(1): 284-286, 2018 01 01.
Article em En | MEDLINE | ID: mdl-29106493
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aterosclerose / Placa Aterosclerótica / Receptor de Morte Celular Programada 1 / Nivolumabe Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aterosclerose / Placa Aterosclerótica / Receptor de Morte Celular Programada 1 / Nivolumabe Idioma: En Ano de publicação: 2018 Tipo de documento: Article